Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapine.
about
A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans.Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230.Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination.An unusual case of underlying rilpivirine resistance in an antiretroviral-naïve man with AIDS.Long-Term Control of Human Immunodeficiency Virus-1 Replication Despite Extensive Resistance to Current Antiretroviral Regimens: Clonal Analysis of Resistance Mutations in Proviral Deoxyribonucleic Acid.High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study.Profile of disposition, tissue distribution and excretion of the novel anti-human immunodeficiency virus (HIV) agent W-1 in rats.Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients.Clinical, virological and immunological features of HIV-positive children internationally adopted in France from 2005-2015
P2860
Q37305526-C936785E-68A8-4F72-B9C3-C7FE0FA6C049Q37305622-C310FCAD-8E1D-4F7B-A96B-C4056486AF01Q38380110-B690D6BA-BE97-4250-89F7-857FD19436ACQ38381059-522B65F0-76A7-4BBF-A0C5-08827C5995A9Q38381504-C37AA146-DBF3-4FEE-8426-4C43D7FFD16BQ38996079-F6F2BCEE-A641-4DF8-9C7B-89C9B7586452Q39980493-5BF88866-7354-437D-BF3C-8CD4B1FFEBA3Q40708931-811833A8-406F-4471-B46F-8649CD14F694Q40836288-77397595-B45D-46E1-B8DA-42DCDCDDEB66Q59126542-7EFF4937-017F-4A42-9692-79EB2F155C8A
P2860
Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapine.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Archived HIV-1 DNA resistance ...... ed to efavirenz or nevirapine.
@en
type
label
Archived HIV-1 DNA resistance ...... ed to efavirenz or nevirapine.
@en
prefLabel
Archived HIV-1 DNA resistance ...... ed to efavirenz or nevirapine.
@en
P2093
P2860
P356
P1476
Archived HIV-1 DNA resistance ...... ed to efavirenz or nevirapine.
@en
P2093
C Delaugerre
I Charreau
J M Molina
J P Aboulker
N de Castro
P2860
P304
P356
10.1093/JAC/DKU395
P407
P577
2014-10-25T00:00:00Z